The Impact of Residual Renal Function on the Adequacy of Peritoneal Dialysis

Popovich R.P. , Moncrief J.W. , Decherd J.F. , Bomar J.B. , Pyle W.K. The definition of a novel portable/wearable equilibrium dialysis technique (Abstract). Trans Am Soc Artif Int Organs 1976; 5: 64.

Popovich R.P. , Moncrief J.W. , Decherd J.F. , Pyle W.K. , Morris S. , Lindley J.D. Clinical developments of the low dialysis clearance hypothesis via equilibrium peritoneal dialysis. Proc Annual Contractors Conf Artif Kidney — Chronic Uremia Prog (NIAMDO) 1977; 10: 123–5.

Rose B.D. Clinical Physiology of Acid-Base and Electrolyte Disorders, 4th ed. New York: McGraw-Hill, 1994; 48–55.

Payne R.B. Creatinine clearance: A redundant clinical investigation. Ann Clin Biochem 1986; 23: 243–50.

Doolan P.D. , Alpen E.L. , Theil G.B. Aclinical appraisal of the plasma concentration and endogenous clearance of creatinine. Am J Med 1962; 32: 65–79.

Kim K.E. , Onesti G. , Ramirez O. , Brest A.N. , Swartz C. Creatinine clearance in renal disease. A reappraisal. Br Med J 1969; 4: 11–14.

Levey A.S. Measurement of renal function in chronic renal disease. Kidney Int 1990; 38: 167–84.

van Acker B.A.C. , Koomen G.C.M. , Koopman M.G. , de Waart D.R. , Arisz L. Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet 1992; 340: 1326–9.

Petri M. , Bockenstedt L. , Colman J. Serial assessment of glomerular filtration rate in lupus nephropathy. Kidney Int 1988; 34: 832–9.

Perrone R.D. , Steinman T.I. , Beck G.J. Utility of radioisotopic filtration markers in chronic renal insufficiency: Simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. Am J Kidney Dis 1990; 16: 224–35.

Hilbrands L.B. , Artz M.A. , Wetzels J.F. , Koene R.A. Cimetidine improves the reliability of creatinine as a marker of glomerular filtration. Kidney Int 1991; 40: 1171–6.

Hiratadulas C.A.I. , Halstenson C.E. , Kasiske B.L. Improvement in the accuracy and precision of creatinine clearance as a measure of glomerular filtration rate with oral cimetidine in renal transplant recipients. Clin Transplant 1993; 7: 552–8.

Agarwal R. Creatinine clearance with cimetidine for measurement of GFR (Letter). Lancet 1993; 341: 188.

Lubowitz H. , Slatopolsky E. , Shankel S. Glomerular filtration rate determination in patients with chronic renal disease. JAMA 1967; 199: 252–6.

van Olden R.W. , Krediet R.T. , Struijk D.G. , Arisz L. Measurement of residual renal function in patients treated with CAPD (Abstract). Sixth Benelux Dial Symp, Brussels, April 8, 1995.

Milutinovic J. , Cutler R.E. , Hoover P. , Meusen B. , Scribner B.H. Measurement of glomerular filtration rate in patients receiving repetitive hemodialysis. Kidney Int 1975; 8: 185–90.

Gaspari F. , Perico N. , Ruggenenti P. Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 1995; 6: 257–63.

Swan S.K. , Halstenson C.E. , Kasiske B.L. , Collins A.J. Determination of residual renal function with iohexol clearance in hemodialysis patients. Kidney Int 1996; 49: 232–5.

Marx M.A. , Shuler C.L. , Tattersall J.E. , Golper T.A. Plasma iohexol clearance as an alternative to creatinine clearance for CAPD adequacy studies. Kidney Int 1995; 48: 1994–7.

Rottembourg J. , Issad B. , Gallego J.L. Evolution of residual renal function in patients undergoing maintenance hemodialysis or continuous ambulatory peritoneal dialysis. Proc EDTA 1983; 19: 397–403.

Nolph K.D. Is residual renal function better preserved with CAPD than with hemodialysis? Am Kidney Fund Nephrol Lett 1990; 7: 1–7.

Lysaght M.J. , Vonesh E.F. , Gotch F. The influence of dialysis treatment modality on the decline of remaining renal function. ASA/O Trans 1991; 37: 598–604.

Rottembourg J. Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int 1993; 43(Suppl 40): S106–10.

Iest C.G. , Vanholder R.C. , Ringoir S.M. Loss of residual renal function in patients on regular hemodialysis. Int J Artif Organs 1989; 12: 154–9.

Hiroshige K. , Yuu K. , Soejima M. , Takasugi M. , Kuroiwa A. Rapid decline of residual renal function in patients on automated peritoneal dialysis. Perit Dial Int 1996; 16: 307–15.

McCarthy J.T. The use of polysulfone dialyzers slows the rate of intrinsic renal function loss in chronic hemodialysis patients (Abstract). J Am Soc Nephrol 1993; 4: 367.

McKane W.S. , Tattersall J.E. , Farrington K. Preservation of residual renal function in high flux haemodialysis (Abstract). Nephrol Dial Transplant 1994; 9: 1686.

Schiffl H. Choice of dialysis membrane does not influence the outcome of residual renal function in haemodialysis patients (Letter). Nephrol Dial Transplant 1995; 10: 611–2.

Van Stone J.C. The effect of dialyzer membrane and etiology of kidney disease on the preservation of residual renal function in chronic hemodialysis patients ASAIO J 1995; 41: M713–6.

Caramelo C. , Alcazar R. , Gallar P. Choice of dialysis membrane does not influence the outcome of residual renal function in haemodialysis patients. Nephrol Dial Transplant 1994, 9: 675–7.

Motojima M. , Nishijima F. , Ikoma M. Role of “uremic toxin” in the progressive loss of intact nephrons in chronic renal failure. Kidney Int 1991; 40: 461–9.

Niwa T. , Ise M. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med 1994; 124: 96–104.

Niwa T. , Yazawa T. , Kodama T. , Uehara Y. , Maeda K. , Yamada K. Efficient removal of albumin-bound furancarbolic acid, an inhibitor of erythropoiesis, by continuous ambulatory peritoneal dialysis. Nephron 1990; 56: 241–5.

Caro J. , Brown S. , Miller O. , Murray T.G. , Erslev A.J. Erythropietin levels in uremic nephric and anephric patients. J Lab Clin Med 1979; 93: 449–54.

Zappacosta A.R. , Caro J. , Erslev A. Normalization of hematocrit in patients with end-stage renal disease on CAPD. The role of erythropoietin. Am J Med 1982; 72: 53–7.

Chandra M. , Clemons G.K. , McVicar M. , Wilkes B. , Mossey R.T. Serum erythropoietin levels and hematocrit in end-stage renal disease: influence of the mode of therapy. Am J Kidney Dis 1988; 12: 208–13.

Jongen M.J.M. , Vander Vijgh W.S.F. , Lip P. , Netelenbos J.C. Measurements of vitamin D metabolites in anephric subjects. Nephron 1984; 36: 230–6.

Blumberg A. , Burgi W. Behaviour of B2 microglobulin in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration and continuous ambulatory peritoneal dialysis. Clin Nephrol 1987; 27: 245–9.

Rottembourg J. , Allouache M. , Mussey L. , Jacobs C. Beta₂ microglobulin in dialyzed patients: hemodialysis versus continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1987; 2: 248–9.

Thielemans C. , Dratwa M. , Bergmann P. Continuous ambulatory peritoneal dialysis versus haemodialysis: A lesser risk of amyloidosis Nephrol Dial Transplant 1988; 3: 291–4.

Acchiacardo S. , Kraus A.P. , Jennings B.R. Beta 2 microglobulin levels in patients with renal insufficiency. Am J Kidney Dis 1989; 13: 70–4.

Scalamogna A. , Imbasciati E. , Devecchi A. Beta 2 microglobulin in patients on peritoneal dialysis and hemodialysis. Perit Dial Int 1989; 9: 37–40.

Montenegro J. , Martinez I. , Saracho R. , Gonzalez R. β₂ microglobulin in CAPD. Adv Perit Dial 1992; 8: 369–72.

Amici G. , Virga G. , Rine Da Serumbeta-2 microglobulin level and residual renal function in peritoneal dialysis. Nephron 1993; 65: 469–71.

Tielemans C. , Dratwa M. , Bergmann P. Continuous ambulatory peritoneal dialysis: a lesser risk of amyloidosis? Nephrol Dial Transplant 1988; 3: 291–4.

Keshaviah P. Adequacy of CAPD: a quantitative approach. Kidney Int 1992; 42(Suppl 38): S160–4.

Nolph K.D. , Twardowski Z.J. , Keshaviah P.R. Weekly clearances of urea and creatinine on CAPD and NIPD. Perit Dial Int 1992; 12: 298–303.

Churchill D.N. , Taylor D.W. , Keshaviah P. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcome. J Am Soc of Nephrol 1996; 7: 198–207.

Faller B. , Lameire N. Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years. Nephrol Dial Transplant 1994; 9: 280–6.

Lameire N. , Vanholder R. , Vijt D. , Lambert M.C. , Ringoir S. A longitudinal five year survey of urea kinetic parameters in CAPD patients. Kidney Int 1992; 42: 426–32.

Watson P.E. , Watson I.D. , Batt R.D. Total body water volumes for adult males and females estimated from simple anthropometric measurements Am J Clin Nutrition 1980; 33: 27–39.

Sherman R.A. Quantitating peritoneal dialysis: the problem with V. Sem Dial 1996; 9: 381–3.

Keshaviah P. Can peritoneal dialysis be equivalent to (or better than) optimal hemodialysis? Sem Dial 1996; 9: 243–5.

Keshaviah P. , Emerson P.F. , Vonesh E.F. , Brandes J.C. Relationship between body size fill volume, and mass transfer area coefficient in peritoneal dialysis. J Am Soc of Nephrol 1994; 4: 1820–6.

Blake P.G. Targets in CAPD and APD prescription. Perit Dial Int 1996; 16: S143–6.

Tattersall J.E. , Doyle S. , Greenwood R.N. , Farrington K. Maintaining adequacy in CAPD by individualizing the dialysis prescription. Nephrol Dial Transplant 1994; 9: 749–52.

Johnston J.R. , Bernardini J. , Holley J. , Piraino B. Effect of increasing exchange volume or frequency on CAPD efficiency (Abstract). Perit Dial Int 1995; 15: S41.

Diaz-Buxo J.A. , Suki W.N. Automated peritoneal dialysis. In: Gokal R. , and Nolph K.D. , eds. The textbook of peritoneal dialysis. Dordrecht, the Netherlands: Kluwer Academic Publishers, 1994; 399–418.

De Fijter C.W. , Oe L.P. , Nauta J.J. Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Int Med 1994; 120: 264–71.

Brunkhorst R. , Wrenger E. , Krautzig S. , Ehlerding G. , Mahiout A. , Koch K.M. Clinical experience with home automated peritoneal dialysis. Kidney Int 1994; 46(Suppl 48): S25–30.

Saldanha L.F. , Weiler E. , Gonick H.C. Effect of continuous ambulatory peritoneal dialysis on blood pressure control. Am J Kidney Dis 1993; 21: 184–8.

Lameire N. , Bernaert P. , Lambert M.C. , Vijt D. Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis. Kidney Int 1994; 46(Suppl 48): S31–8.

Charra B. , Calemard E. , Ruffet M. Survival as an index of adequacy of dialysis. Kidney Int 1992; 41: 1286–91.

Charra B. , Calemard E. , Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 1996; 16: 35–44.

Davies S.J. , Bryan J. , Phillips L. , Russel G.I. The predictive value of KT/V and peritoneal solute transport in CAPD patients is dependent on the type of comorbidity present. Perit Dial Int 1996; 16(Suppl 1): S158–62.

Heimburger O. , Waniewski J. , Werynski A. , Tranaeus A. , Lindholm B. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 1990; 38: 495–506.

Selgas R. , Fedez-Reyes M.J. , Bosque E. Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. Am J Kidney Dis 1994; 23: 64–73.

Selgas R. , Bajo M.A. , Del Peso G. , Jimenez C. Preserving the peritoneal membrane in long-term peritoneal dialysis patients. Sem Dial 1995; 8: 326–32.

Fliser D. , Schroder M. , Neubeck M. , Ritz E. Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney Int 1994; 46: 482–8.

Scarpioni L. , Ballochi S. , Bergonzi G. , Fontana F. , Poisetti P. , Zanazzi M.A. High dose diuretics in continuous ambulatory peritoneal dialysis. Perit Dial Bull 1982; 2: 177–8.

Grantham J.J. , Chonko A.M. The physiologic basis and clinical use of diuretics. In: Brenner B.M. , Stein J.H. , eds. Contemporary Issues in Nephrology: Sodium and Water Homeostais. New York: Churchill Livingstone, 1978; 178–211

Schulman G. , Hakim R.M. Improving outcomes in chronic hemodialysis patients: should dialysis be initiated earlier? Sem Dial 1996; 9: 225–9.

Tattersall J. , Greenwood R. , Farrington K. Ureakinetics and when to commence dialysis. Am J Nephrol 1995; 15: 283–9.